NewslettersImmune Regulation NewsDual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian CancerBy lbeveridge - July 21, 20220380The dual CDK12/CDK13 inhibitor ZSQ836 exerted potent anticancer activity in cell culture and mouse models and induced transcriptional reprogramming, including downregulation of DNA damage response genes.[Cancer Research]Abstract